Triple
T195379
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Biogen |
E3807
|
entity |
| Predicate | hasProduct |
P3585
|
FINISHED |
| Object |
Leqembi
Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
|
E25439
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a2548debd48190ae3a06d6e65b53c6 |
elicitation | completed |
| NER | batch_69a25969425081908e178db8ba4631c2 |
ner | completed |
| NED1 | batch_69a31c91b22c8190a1d04983ae4fd793 |
ned_source_triple | completed |
| NED2 | batch_69a31efbe2d48190b528011dfdf764c1 |
ned_description | completed |
| NEDg | batch_69a31ea66b8881909748ab11d7a4a50a |
nedg | completed |
Created at: Feb. 28, 2026, 2:41 a.m.